Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Keryx Biopharma Down 17% Despite Drug Approval
Keryx Biopharma Down 17% Despite Drug Approval
Keryx Biopharma Down 17% Despite Drug Approval
Submitted by
admin
on November 14, 2017 - 7:56pm
Source:
Motley Fool
News Tags:
Keryx
FDA
Auryxia
chronic kidney disease
dialysis
Headline:
Keryx Biopharma Down 17% Despite Drug Approval
Do Not Allow Advertisers to Use My Personal information
